Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexamethasone versus magnesium sulfate versus saline for prevention of post-extubation sore throat
IRCT20141009019470N86Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone and magnesium sulfate in pharyngitis (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Post-extubation sore throat incidence, Post-extubation sore throat severity and 1 more. Started Sep 2019; status: completed.
02
Drugs
dexamethasonemagnesium sulfate
03
Conditions
pharyngitis
Beyond the preview
Go deeper on IRCT20141009019470N86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N86.